GHRP-6 (5mg) Dosage Protocol
GHRP-6 (Growth Hormone Releasing Peptide-6) is a hexapeptide that stimulates GH release through the ghrelin receptor. It also significantly increases appetite.
Add 2.0 mL bacteriostatic water → 2.5 mg/mL (2500 mcg/mL)
100 mcg 2-3 times daily (200-300 mcg total)
At 2.5 mg/mL: 4 units = 100 mcg
Lyophilized: -20°C; Reconstituted: 2-8°C for up to 4 weeks
| Week | Daily Dose | Units (per injection) |
|---|---|---|
| Weeks 1-4 | 100 mcg 2x daily | 4 units per dose |
| Weeks 5-8 | 100 mcg 3x daily | 4 units per dose |
| Weeks 9-12 | 100-150 mcg 3x daily | 4-6 units per dose |
- 1Draw 2.0 mL bacteriostatic water with a sterile syringe
- 2Inject slowly down the vial wall to prevent foaming
- 3Gently swirl until fully dissolved - do not shake
- 4Label with date and concentration, refrigerate immediately
GHRP-6 stimulates GH release through the ghrelin/GHS receptor. Phase I studies tested doses of 100, 200, and 400 mcg/kg. Half-life is approximately 2.5 hours. Unlike Ipamorelin, GHRP-6 significantly increases appetite and may raise cortisol and prolactin.
- Potent GH release stimulation
- Increases appetite significantly
- Supports muscle growth and recovery
- May improve sleep quality
- Cabrales A, et al. Pharmacokinetic study of GHRP-6. Eur J Pharm Sci. 2013;48(1-2):40-6
- Berlanga-Acosta J, et al. Synthetic GHRPs. Endocr Metab Immune Disord Drug Targets. 2017;17(1):13-24
- Bellone J, et al. GH-releasing effect of oral GHRP-6. Eur J Endocrinol. 1995;133(4):425-8
Lyophilized
Store at -20°C, protected from light
Reconstituted
Refrigerate at 2-8°C, use within 4 weeks
Must be administered on empty stomach
- •Research compound - not FDA approved
- •Causes significant hunger increase
- •May increase cortisol and prolactin
- •Best combined with GHRH for synergy
Disclaimer: This content is intended for research and educational purposes only. Not intended to diagnose, treat, cure, or prevent any disease. All compounds are for research use only. Dosing information is derived from published scientific literature and clinical studies.